Efficacy of human papillomavirus (HPV)-16/18 ASO4-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenPAAVONEN, J; NAUD, P; HEDRICK, J et al.Lancet (British edition). 2009, Vol 374, Num 9686, pp 301-314, issn 0140-6736, 14 p.Article

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15―25 years with and without serological evidence of previous exposure to HPV-16/18SZAREWSKI, A; POPPE, W. A. J; CASTELLSAGUE, X et al.International journal of cancer (Print). 2012, Vol 131, Num 1, pp 106-116, issn 0020-7136, 11 p.Article

Acetic-acid guided visual inspection vs. cytology-based screening for cervical cancer in the PhilippinesNGELANGEL, C. A; LIMSON, G. M; CORDERO, C. P et al.International journal of gynaecology and obstetrics. 2003, Vol 83, Num 2, pp 141-150, issn 0020-7292, 10 p.Article

Causes of cervical cancer in the Philippines : A case-control studyNGELANGEL, C; MUNOZ, N; BOSCH, F. X et al.Journal of the National Cancer Institute. 1998, Vol 90, Num 1, pp 43-49, issn 0027-8874Article